|
 |
 |
 |
Feed: NATURENEWS - MOST RECENT ARTICLES - NATURE.COM SCIENCE FEEDS
Nature - the world's best science and medicine on your desktop
Minnesota starts to destroy stored blood spots
By: Meredith Wadman
Court ruling that the state must get consent to store samples from newborn screening could hinder biomedical research.
Isotopes hint at North Korean nuclear test
By: Geoff Brumfiel
Data suggest that the country has experimented with a fusion boost to its fission weapons.
Europe's research plan starts to take shape
By: Lucas Laursen
Teresa Riera Madurell describes her goals for the Horizon 2020 funding programme.
Malaria death toll disputed
By: Zoe Cormier
Study doubles official estimate, but scientists say its methods are flawed.
Norway to bring cancer-gene tests to the clinic
By: Ewen Callaway
A pilot programme will use latest tumour-sequencing techniques to help guide cancer care.
Researchers feel pressure to cite superfluous papers
By: Richard Van Noorden
First survey to quantify problem finds that junior faculty are more likely to be targeted.
One genome from many
By: Virginia Gewin
Researchers extract genome for single organism from water sample.
Questions hang over red-wine chemical
By: Ewen Callaway
How resveratrol benefits health a matter of debate.
Global health hits crisis point
By: Laurie Garrett
The Global Fund's drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett.
Seven days: 27 January–2 February 2012
By:
The week in science: sequencing stock rebounds after takeover bid for Illumina; drug companies and nations team up against neglected diseases; and turmoil at the Global Fund.
Genomics ace quits Japan
By: David Cyranoski
Yusuke Nakamura blames government inertia for his move to the United States.
Japan plans to merge major science bodies
By: Ichiko Fuyuno
Drive to save money could increase bureaucracy.
Marine ecology: Attack of the blobs
By: Mark Schrope
Jellyfish will bloom as ocean health declines, warn biologists. Are they already taking over?
Vaccine development: Man vs MRSA
By: Maryn McKenna
For decades, Robert Daum has studied the havoc wreaked by methicillin-resistant Staphylococcus aureus . Now he thinks he can stop it for good.
Success through cooperation
By: Heidi Ledford
Anders Ekblom, head of science and integration at AstraZeneca, explains that the future of drug discovery lies in 'predictive innovation'.
|